Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/26334
Title: | Treatment choices based on multiplatform profiling platform, unlike those with sequencing alone, do not cause a cost explosion in refractory cancer patients | Authors: | Russell, K. J. JANSSENS, Jaak Dean, A. Hernandez, A. Voss, A. |
Issue Date: | 2017 | Publisher: | ELSEVIER SCIENCE INC | Source: | VALUE IN HEALTH, 20(9), p. A579-A579 (Art N° PMD42) | Notes: | [Russell, K. J.; Hernandez, A.; Voss, A.] Caris Life Sci, Basel, Switzerland. [Janssens, J.] Univ Hasselt, Hasselt, Belgium. [Dean, A.] St John God Hosp, Subiaco, WA, Australia. | Document URI: | http://hdl.handle.net/1942/26334 | ISSN: | 1098-3015 | e-ISSN: | 1524-4733 | DOI: | 10.1016/j.jval.2017.08.1026 | ISI #: | 000413599901365 | Rights: | © 2017 Published by Elsevier Inc. | Category: | M | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
russell 2.pdf Restricted Access | Published version | 58.92 kB | Adobe PDF | View/Open Request a copy |
WEB OF SCIENCETM
Citations
1
checked on Sep 26, 2024
Page view(s)
48
checked on Sep 7, 2022
Download(s)
40
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.